Study: NCT02027454

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GSK1265744
Description: White to slightly colored film coated tablet with unit dose strength of 30 mg and dose level of 150mg (5 tablets of 3 mg) administered orally every 12hours for 3 doses.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GSK1265744
Description: White to slightly colored film coated tablet with unit dose strength of 30 mg and dose level of 150mg (5 tablets of 3 mg) administered orally every 12hours for 3 doses.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GSK1265744
Description: White to slightly colored film coated tablet with unit dose strength of 30 mg and dose level of 150mg (5 tablets of 3 mg) administered orally every 12hours for 3 doses.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GSK1265744
Description: White to slightly colored film coated tablet with unit dose strength of 30 mg and dose level of 150mg (5 tablets of 3 mg) administered orally every 12hours for 3 doses.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GSK1265744
Description: White to slightly colored film coated tablet with unit dose strength of 30 mg and dose level of 150mg (5 tablets of 3 mg) administered orally every 12hours for 3 doses.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GSK1265744
Description: White to slightly colored film coated tablet with unit dose strength of 30 mg and dose level of 150mg (5 tablets of 3 mg) administered orally every 12hours for 3 doses.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GSK1265744 matching placebo
Description: GSK1265744 matching placebo tablets administered orally every 12hours for 3 doses (5 tablets per dose).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GSK1265744 matching placebo
Description: GSK1265744 matching placebo tablets administered orally every 12hours for 3 doses (5 tablets per dose).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GSK1265744 matching placebo
Description: GSK1265744 matching placebo tablets administered orally every 12hours for 3 doses (5 tablets per dose).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GSK1265744 matching placebo
Description: GSK1265744 matching placebo tablets administered orally every 12hours for 3 doses (5 tablets per dose).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GSK1265744 matching placebo
Description: GSK1265744 matching placebo tablets administered orally every 12hours for 3 doses (5 tablets per dose).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GSK1265744 matching placebo
Description: GSK1265744 matching placebo tablets administered orally every 12hours for 3 doses (5 tablets per dose).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Moxifloxacin
Description: Dull red, oblong, convex film coated tablets with unit dose strength of 400 mg administered orally as a single dose.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Moxifloxacin
Description: Dull red, oblong, convex film coated tablets with unit dose strength of 400 mg administered orally as a single dose.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Moxifloxacin
Description: Dull red, oblong, convex film coated tablets with unit dose strength of 400 mg administered orally as a single dose.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Moxifloxacin
Description: Dull red, oblong, convex film coated tablets with unit dose strength of 400 mg administered orally as a single dose.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Moxifloxacin
Description: Dull red, oblong, convex film coated tablets with unit dose strength of 400 mg administered orally as a single dose.